X Y Feng

6.5k citations
196 papers · 3.9k indexed · 2 hit papers · h-index 30
Topics
Hepatocellular Carcinoma Treatment and Prognosis (58 papers)Liver Disease Diagnosis and Treatment (30 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers)

In The Last Decade

X Y Feng

177 papers receiving 3.8k citations

Hit Papers

A randomized controlled trial of radiofrequency ablation ...201220262016202120122023100200300400500

Peers

X Y Feng
Comparison fields: 5 of 151
  • Molecular Biology 1.2k
  • Hepatology 1.2k
  • Epidemiology 838
  • Surgery 731
  • Oncology 682
Replace Keqing Shi with:
Keqing Shi China
Ali Zarrinpar United States
Bruno Turlin France
Jean Rosenbaum France
Olaf Dirsch Germany
Ligong Lu China
Jin‐hong Park South Korea
Kwon‐Ha Yoon South Korea
Katsunori Yoshida Japan
Orit Pappo Israel
X Y Feng relative to Keqing Shi China Keqing Shi's profile →
Citations per field
00.5×1.5×
Keqing Shi · 1×
Citations per year

Countries citing papers authored by X Y Feng

Since Specialization
Citations

This map shows the geographic impact of X Y Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X Y Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X Y Feng more than expected).

Fields of papers citing papers by X Y Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X Y Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X Y Feng. The network helps show where X Y Feng may publish in the future.

Co-authorship network of co-authors of X Y Feng

This figure shows the co-authorship network connecting the top 25 collaborators of X Y Feng. A scholar is included among the top collaborators of X Y Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X Y Feng. X Y Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 6
4 1
5 0
6 14
7 5
8 2
9 0
10 12
11 9
12 3
13 11
14 11
15 0
16 74
17 4
18 66
19 10
20
Structural study on plateau adaptability of yak lung
4

About X Y Feng

X Y Feng is a scholar working on Hepatology, Virology and Epidemiology, having authored 196 papers that have together received 3.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (58 papers), Liver Disease Diagnosis and Treatment (30 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (631 citations) and Oncology (682 citations). X Y Feng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ping Bie, Kuansheng Ma, Xiaowu Li, Shuguang Wang, Jun Yan, Kai Feng, Cheng Qian, Jiahong Dong, Yanmin Xu and Juanjuan Shan. Their work appears in journals such as Applied Physics Letters, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026